Chemical Works Of Gedeon Richter Plc has released a press release.
Half-yearly Report 2026 H1
Earlier from Chemical Works Of Gedeon Richter
- Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care
- Bond interest payment
- Gedeon Richter: Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)
- Gedeon Richter: Richter and Acrux agree to license Lenzetto® for Australia